| Dr John Chadwick King, MD | |
|
400 N State Of Franklin Rd, Johnson City, TN 37604-6035 | |
| (423) 431-6389 | |
| (423) 431-6331 |
| Full Name | Dr John Chadwick King |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 37 Years |
| Location | 400 N State Of Franklin Rd, Johnson City, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396710505 | NPI | - | NPPES |
| 64927247 | Medicaid | KY | |
| 6644686 | Medicaid | VA | |
| 3019657 | Other | TN | BCBS |
| 3068386 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD23456 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johnson City Medical Center | Johnson city, TN | Hospital |
| Johnston Memorial Hospital | Abingdon, VA | Hospital |
| Franklin Woods Community Hospital | Johnson city, TN | Hospital |
| Greeneville Community Hospital | Greeneville, TN | Hospital |
| Sycamore Shoals Hospital | Elizabethton, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Watauga Pathology Associates Pc | 4183718380 | 11 |
News Archive
Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga® (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.
Researchers have identified an important cancer gene that could lead to more effective drugs being developed to fight paediatric high grade glioma, a disease which currently has a poor prognosis.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has accepted for standard review the Company's supplemental Biologics License Application for EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema.
Urban Institute/Robert Wood Johnson Foundation: The Health Status Of New Medicaid Enrollees Under Health Reform - Using the Medical Expenditure Panel Survey, authors of this paper found "strong evidence that those who will enroll [in Medicaid after 2014] are likely to be healthier than nondisabled adults currently enrolled in Medicaid ... There is, however, a high likelihood of adverse selection - the least healthy and older among the new eligibles will be more likely to enroll.
Pfizer Inc. today announced that it has entered into a definitive agreement to purchase Ferrosan's consumer healthcare business, which includes dietary supplements and lifestyle products, from Altor 2003 Fund GP Limited.
› Verified 3 days ago
| Entity Name | Watauga Pathology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720053945 PECOS PAC ID: 4183718380 Enrollment ID: O20070919000360 |
News Archive
Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga® (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.
Researchers have identified an important cancer gene that could lead to more effective drugs being developed to fight paediatric high grade glioma, a disease which currently has a poor prognosis.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has accepted for standard review the Company's supplemental Biologics License Application for EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema.
Urban Institute/Robert Wood Johnson Foundation: The Health Status Of New Medicaid Enrollees Under Health Reform - Using the Medical Expenditure Panel Survey, authors of this paper found "strong evidence that those who will enroll [in Medicaid after 2014] are likely to be healthier than nondisabled adults currently enrolled in Medicaid ... There is, however, a high likelihood of adverse selection - the least healthy and older among the new eligibles will be more likely to enroll.
Pfizer Inc. today announced that it has entered into a definitive agreement to purchase Ferrosan's consumer healthcare business, which includes dietary supplements and lifestyle products, from Altor 2003 Fund GP Limited.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Chadwick King, MD Po Box 52990, Greenwood, SC 29649-0048 Ph: (864) 223-3600 | Dr John Chadwick King, MD 400 N State Of Franklin Rd, Johnson City, TN 37604-6035 Ph: (423) 431-6389 |
News Archive
Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga® (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.
Researchers have identified an important cancer gene that could lead to more effective drugs being developed to fight paediatric high grade glioma, a disease which currently has a poor prognosis.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has accepted for standard review the Company's supplemental Biologics License Application for EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema.
Urban Institute/Robert Wood Johnson Foundation: The Health Status Of New Medicaid Enrollees Under Health Reform - Using the Medical Expenditure Panel Survey, authors of this paper found "strong evidence that those who will enroll [in Medicaid after 2014] are likely to be healthier than nondisabled adults currently enrolled in Medicaid ... There is, however, a high likelihood of adverse selection - the least healthy and older among the new eligibles will be more likely to enroll.
Pfizer Inc. today announced that it has entered into a definitive agreement to purchase Ferrosan's consumer healthcare business, which includes dietary supplements and lifestyle products, from Altor 2003 Fund GP Limited.
› Verified 3 days ago
Emily R Patterson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Market St, Johnson City, TN 37604 Phone: 423-431-1386 | |
Dr. Thomas M Soike, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 400 N State Of Franklin Rd, Johnson City, TN 37604 Phone: 423-431-1310 Fax: 423-431-6331 | |
Dr. David Richard Soike, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 400 N State Of Franklin Rd, Johnson City, TN 37604 Phone: 423-431-6388 Fax: 423-431-6331 | |
Dr. Julie Elisabeth Robertson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 400 N State Of Franklin Rd, Johnson City, TN 37604 Phone: 423-431-6389 Fax: 423-431-6331 | |
Theresa F Lura, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 325 N State Of Franklin Rd, Johnson City, TN 37604 Phone: 423-439-8849 Fax: 423-439-8110 | |
Rowena Velilla, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2203 Lakeland Dr, Johnson City, TN 37601 Phone: 423-926-1496 Fax: 423-979-3401 |